ANDA Pulse

Veeda is your Pulse on news effecting your ANDA submission Veeda Clinical Research brings you the ANDA Pulse, a quarterly newsletter focused to help you with your generic drug development and ANDA submissions. The ANDA Pulse will be loaded with news on all aspects of information related to Global regulatory laws, the changing face of generic drugs, the Hatch Waxman act its implications, proposals at various important forums like the USFDA, MHRA and the DCGI. This Newsletter will be delivered to you in an electronic format in your emails.

To receive a free email subscription simply fill out your contact information by clicking on the subscribe to Veeda CR Newsletter link below. You will be taken to our subscription section. All information is confidential and will not be shared with anyone outside of Veeda CR Ltd.

Each new issue will automatically be forwarded in Adobe Acrobat® format as an attachment. If you need the viewer for this format, please download the Adobe Acrobat® Reader® by clicking on the Adobe button below.